1. Robins, E. & Guze, S. B. Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am. J. Psychiatry 126, 983–987 (1970).

2. Kendell, R. & Jablensky, A. Distinguishing between the validity and utility of psychiatric diagnoses. Am. J. Psychiatry 160, 4–12 (2003).

3. Krystal, J. H. & State, M. W. Psychiatric disorders: diagnosis to therapy. Cell 157, 201–214 (2014).

4. O’Donovan, M. C. & Owen, M. J. The implications of the shared genetics of psychiatric disorders. Nat. Med. 22, 1214–1219 (2016).

5. Doherty, J. L. & Owen, M. J. Genomic insights into the overlap between psychiatric disorders: implications for research and clinical practice. Genome Med. 6, 29 (2014).

6. Widiger, T. A. & Sankis, L. M. Adult psychopathology: issues and controversies. Annu. Rev. Psychol. 51, 377–404 (2000).

7. Bulik, C. M., Prescott, C. A. & Kendler, K. S. Features of childhood sexual abuse and the development of psychiatric and substance use disorders. Br. J. Psychiatry 179, 444–449 (2001).

8. Brown, G. W., Harris, T. O. & Eales, M. J. Social factors and comorbidity of depressive and anxiety disorders. Br. J. Psychiatry Suppl. 168, 50–57 (1996).

9. Gorman, J. M. & Kent, J. M. SSRIs and SNRIs: broad spectrum of efficacy beyond major depression. J. Clin. Psychiatry 60 (Suppl.4), 33–38 (1999).

10. Polderman, T. J. et al. Meta-analysis of the heritability of human traits based on fifty years of twin studies. Nat. Genet. 47, 702–709 (2015).

11. Lichtenstein, P. et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 373, 234–239 (2009).

12. Sullivan, P. F. et al. Family history of schizophrenia and bipolar disorder as risk factors for autism. Arch. Gen. Psychiatry 69, 1099–1103 (2012).

13. Larsson, H. et al. Risk of bipolar disorder and schizophrenia in relatives of people with attention-deficit hyperactivity disorder. Br. J. Psychiatry 203, 103–106 (2013).

14. Lee, S. H. et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat. Genet. 45, 984–994 (2013).

15. Bulik-Sullivan, B. et al. An atlas of genetic correlations across human diseases and traits. Nat. Genet. 47, 1236–1241 (2015).

16. Wray, N. R. et al. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat. Genet. 50, 668–681 (2018).

17. Hamshere, M. L. et al. Shared polygenic contribution between childhood attention-deficit hyperactivity disorder and adult schizophrenia. Br. J. Psychiatry 203, 107–111 (2013).

18. Demontis, D. et al. Discovery of the first genome-wide significant risk loci for ADHD. Nat.Genet. 51, 63–75 (2019).

19. Grove, J. et al. Common risk variants identified in autism spectrum disorder. Preprint at bioRxiv https://doi.org/10.1101/224774 (2017).

20. Kirov, G. et al. The penetrance of copy number variations for schizophrenia and developmental delay. Biol. Psychiatry 75, 378–385 (2014).

21. Green Snyder, L. et al. Autism spectrum disorder, developmental and psychiatric features in 16p11.2 duplication. J. Autism. Dev. Disord. 46, 2734–2748 (2016).

22. Schneider, M. et al. Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 deletion syndrome. Am. J. Psychiatry 171, 627–639 (2014).

23. Rujescu, D. et al. Disruption of the neurexin 1 gene is associated with schizophrenia. Hum. Mol. Genet. 18, 988–996 (2009).

24. Gandal, M. J. et al. Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap. Science 359, 693–697 (2018).

25. Pedersen, C. B. et al. The iPSYCH2012 case-cohort sample: new directions for unravelling genetic and environmental architectures of severe mental disorders. Mol. Psychiatry 23, 6–14 (2018).

26. Hyde, C. L. et al. Identification of 15 genetic loci associated with risk of major depression in individuals of European descent. Nat. Genet. 48, 1031–1036 (2016).

27. Finucane, H. K. et al. Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types. Nat. Genet. 50, 621–629 (2018).

28. Parikshak, N. N. et al. Integrative functional genomic analyses implicate specific molecular pathways and circuits in autism. Cell 155, 1008–1021 (2013).

29. Network and Pathway Analysis Subgroup of Psychiatric Genomics Consortium. Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. Nat. Neurosci. 18, 199–209 (2015).

30. Bender, A. T. & Beavo, J. A. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol. Rev. 58, 488–520 (2006).

31. Wishart, D. S. et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 46(D1), D1074–D1082 (2018).

32. Munton, R. P., Vizi, S. & Mansuy, I. M. The role of protein phosphatase-1 in the modulation of synaptic and structural plasticity. FEBS Lett. 567, 121–128 (2004).

33. Han, Q. J. et al. IPP5 inhibits neurite growth in primary sensory neurons by maintaining TGF-β/Smad signaling. J. Cell Sci. 126, 542–553 (2013).

34. Kosmicki, J. A. et al. Refining the role of de novo protein-truncating variants in neurodevelopmental disorders by using population reference samples. Nat. Genet. 49, 504–510 (2017).

35. Sanders, S. J. et al. Insights into autism spectrum disorder genomic architecture and biology from 71 risk loci. Neuron 87, 1215–1233 (2015).

36. Fishilevich, S. et al. GeneHancer: genome-wide integration of enhancers and target genes in GeneCards. Database (Oxford) 2017 https://doi.org/10.1093/database/bax028 (2017).

37. Glatt, S. J. et al. Similarities and differences in peripheral blood gene-expression signatures of individuals with schizophrenia and their first-degree biological relatives. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 156B, 869–887 (2011).

38. Dela Peña, I. et al. Common prefrontal cortical gene expression profiles between adolescent SHR/NCrl and WKY/NCrl rats which showed inattention behavior. Behav. Brain. Res. 291, 268–276 (2015).

39. Jang, S. et al. Synaptic adhesion molecule IgSF11 regulates synaptic transmission and plasticity. Nat. Neurosci. 19, 84–93 (2016).

40. Breiderhoff, T. et al. Sortilin-related receptor SORCS3 is a postsynaptic modulator of synaptic depression and fear extinction. PLoS ONE 8, e75006 (2013).

41. Cohen, P. & Cohen, J. The clinician’s illusion. Arch. Gen. Psychiatry 41, 1178–1182 (1984).

42. Meier, S. M. et al. High loading of polygenic risk in cases with chronic schizophrenia. Mol. Psychiatry 21, 969–974 (2016).

43. Yap, C. X. et al. Misestimation of heritability and prediction accuracy of male-pattern baldness. Nat. Commun. 9, 2537 (2018).

44. Wray, N. R., Lee, S. H. & Kendler, K. S. Impact of diagnostic misclassification on estimation of genetic correlations using genome-wide genotypes. Eur. J. Hum. Genet. 20, 668–674 (2012).

45. Jakobsen, K. D., Frederiksen, J. N., Parnas, J. & Werge, T. Diagnostic agreement of schizophrenia spectrum disorders among chronic patients with functional psychoses. Psychopathology 39, 269–276 (2006).

46. Lauritsen, M. B. et al. Validity of childhood autism in the Danish Psychiatric Central Register: findings from a cohort sample born 1990-1999. J. Autism. Dev. Disord. 40, 139–148 (2010).

47. Schork, A. et al. Exploring contributors to variability in estimates of SNP-heritability and genetic correlations from the iPSYCH case-cohort and published meta-studies of major psychiatric disorders. Preprint at bioRxiv https://doi.org/10.1101/487116 (2018).

48. Sudlow, C. et al. UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS. Med. 12, e1001779 (2015).

49. Wang, K., Gaitsch, H., Poon, H., Cox, N. J. & Rzhetsky, A. Classification of common human diseases derived from shared genetic and environmental determinants. Nat. Genet. 49, 1319–1325 (2017).

50. Mortensen, P. B. et al. Effects of family history and place and season of birth on the risk of schizophrenia. N. Engl. J. Med. 340, 603–608 (1999).

51. Pedersen, C. B. The Danish civil registration system. Scand. J. Public Health 39, 22–25 (2011). Suppl.

52. Lynge, E., Sandegaard, J. L. & Rebolj, M. The Danish national patient register. Scand. J. Public Health 39, 30–33 (2011). Suppl.

53. Mors, O., Perto, G. P. & Mortensen, P. B. The Danish psychiatric central research register. Scand. J. Public Health 39, 54–57 (2011). Suppl.

54. Nørgaard-Pedersen, B. & Hougaard, D. M. Storage policies and use of the Danish newborn screening biobank. J. Inherit. Metab. Dis. 30, 530–536 (2007).

55. Cross-Disorder Group of the Psychiatric Genomics Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 381, 1371–1379 (2013).

56. Pedersen, C. B. et al. A comprehensive nationwide study of the incidence rate and lifetime risk for treated mental disorders. JAMA Psychiatry 71, 573–581 (2014).

57. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: diagnostic criteria for Research. (WHO: Geneva, 1993). http://www.who.int/iris/handle/10665/37108.

58. World Health Organization. Klassifikation af sygdomme; Udvidet dansk-latinsk udgave af verdenssundhedsorganisationens internationale klassifikation af sygdomme. 8 revision, 1965 [Classification of diseases: Extended Danish-Latin version of the World Health Organization International Classification of Diseases, 8th revision, 1965] (Danish National Board of Health, Copenhagen, 1971).

59. O’Connell, J. et al. Haplotype estimation for biobank-scale data sets. Nat. Genet. 48, 817–820 (2016).

60. Howie, B. N., Donnelly, P. & Marchini, J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS. Genet. 5, e1000529 (2009).

61. Auton, A. et al. A global reference for human genetic variation. Nature 526, 68–74 (2015).

62. Price, A. L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904–909 (2006).

63. Patterson, N., Price, A. L. & Reich, D. Population structure and eigenanalysis. PLoS. Genet. 2, e190 (2006).

64. Manichaikul, A. et al. Robust relationship inference in genome-wide association studies. Bioinformatics 26, 2867–2873 (2010).

65. Yang, J. et al. Common SNPs explain a large proportion of the heritability for human height. Nat. Genet. 42, 565–569 (2010).

66. Yang, J., Lee, S. H., Goddard, M. E. & Visscher, P. M. GCTA: a tool for genome-wide complex trait analysis. Am. J. Hum. Genet. 88, 76–82 (2011).

67. Lee, S. H., Wray, N. R., Goddard, M. E. & Visscher, P. M. Estimating missing heritability for disease from genome-wide association studies. Am. J. Hum. Genet. 88, 294–305 (2011).

68. Lee, S. H., Yang, J., Goddard, M. E., Visscher, P. M. & Wray, N. R. Estimation of pleiotropy between complex diseases using single-nucleotide polymorphism-derived genomic relationships and restricted maximum likelihood. Bioinformatics 28, 2540–2542 (2012).

69. Neale, B. M. et al. Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry 49, 884–897 (2010).

70. Ripke, S. et al. A mega-analysis of genome-wide association studies for major depressive disorder. Mol. Psychiatry 18, 497–511 (2013).

71. Duncan, L. et al. Significant locus and metabolic genetic correlations revealed in genome-wide association study of anorexia nervosa. Am. J. Psychiatry 174, 850–858 (2017).

72. Autism Spectrum Disorders Working Group of The Psychiatric Genomics Consortium. Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia. Mol. Autism 8, 21 (2017).

73. Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421–427 (2014).

74. Hou, L. et al. Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder. Hum. Mol. Genet. 25, 3383–3394 (2016).

75. MacArthur, J. et al. The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog). Nucleic Acids Res. 45(D1), D896–D901 (2017).

76. Bulik-Sullivan, B. K. et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291–295 (2015).

77. Chang, C. C. et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience 4, 7 (2015).

78. Devlin, B. & Roeder, K. Genomic control for association studies. Biometrics 55, 997–1004 (1999).

79. Sun, L., Craiu, R. V., Paterson, A. D. & Bull, S. B. Stratified false discovery control for large-scale hypothesis testing with application to genome-wide association studies. Genet. Epidemiol. 30, 519–530 (2006).

80. Storey, J. D. & Tibshirani, R. Statistical significance for genomewide studies. Proc. Natl Acad. Sci. U.SA. 100, 9440–9445 (2003).

81. Benner, C. et al. FINEMAP: efficient variable selection using summary data from genome-wide association studies. Bioinformatics 32, 1493–1501 (2016).

82. Hormozdiari, F., Kostem, E., Kang, E. Y., Pasaniuc, B. & Eskin, E. Identifying causal variants at loci with multiple signals of association. Genetics 198, 497–508 (2014).

83. GTEx Consortium. Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 348, 648–660 (2015).

84. Pers, T. H. et al. Biological interpretation of genome-wide association studies using predicted gene functions. Nat. Commun. 6, 5890 (2015).

85. Kundaje, A. et al. Integrative analysis of 111 reference human epigenomes. Nature 518, 317–330 (2015).

86. Won, H. et al. Chromosome conformation elucidates regulatory relationships in developing human brain. Nature 538, 523–527 (2016).

87. Zambon, A. C. et al. GO-Elite: a flexible solution for pathway and ontology over-representation. Bioinformatics 28, 2209–2210 (2012).

88. Kasprzyk, A. et al. EnsMart: a generic system for fast and flexible access to biological data. Genome Res. 14, 160–169 (2004).

89. Kang, H. J. et al. Spatio-temporal transcriptome of the human brain. Nature 478, 483–489 (2011).